The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma

References

• Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol. 2014;16(7):896–913.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yan LF, Zhang X, et al. Glioma grading on conventional MR images: a deep learning study with transfer learning. Front Neurosci. 2018;12(804):804.
   PubMedGoogle Scholar
• Youssef G, Miller JJ. Lower grade gliomas. Curr Neurol Neurosci Rep. 2020;20(7):21.
   PubMed Web of Science ®Google Scholar
• McDuff SGR, Dietrich J, Atkins KM, et al. Radiation and chemotherapy for high-risk lower grade gliomas: choosing between temozolomide and PCV. Cancer Med. 2020;9(1):3–11.
   PubMed Web of Science ®Google Scholar
• Paul PK, Rabaglia ME, Wang CY, et al. Histone chaperone ASF1B promotes human beta-cell proliferation via recruitment of histone H3.3. Cell Cycle. 2016;15(23):3191–3202.
   PubMed Web of Science ®Google Scholar
• Abascal F, Corpet A, Gurard-Levin ZA, et al. Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Mol Biol Evol. 2013;30(8):1853–1866.
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhang J, Zheng Y, et al. Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma. Per Med. 2021;18(2):115–127.
   PubMed Web of Science ®Google Scholar
• Liu X, Song J, Zhang Y, et al. ASF1B promotes cervical cancer progression through stabilization of CDK9. Cell Death Dis. 2020;11(8):705.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhang Z, Chen X. Overexpression of PKMYT1 facilitates tumour development and is correlated with poor prognosis in clear cell renal cell carcinoma. Med Sci Monit. 2020;26:e926755.
   PubMed Web of Science ®Google Scholar
• Jiangqiao Z, Tao Q, Zhongbao C, et al. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma. Biochem Biophys Res Commun. 2019;511(1):165–172.
   PubMed Web of Science ®Google Scholar
• Han G, Zhang X, Liu P, et al. Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer. Int J Oncol. 2018;53(5):2056–2066.
   PubMed Web of Science ®Google Scholar
• Zhao ZJ, Wei DP, Zheng RZ, et al. The gene coexpression analysis identifies functional modules dynamically changed after traumatic brain injury. Comput Math Methods Med. 2021;2021:5511598.
   PubMedGoogle Scholar
• Ibrahim K, Abdul Murad NA, Harun R, et al. Knockdown of tousledlike kinase 1 inhibits survival of glioblastoma multiforme cells. Int J Mol Med. 2020;46(2):685–699.
   PubMed Web of Science ®Google Scholar
• Hu S, Wang H, Yan D, et al. Loss of miR-16 contributes to tumour progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma. Cell Cycle. 2018;17(18):2284–2295.
   PubMed Web of Science ®Google Scholar
• Takayama Y, Kokuryo T, Yokoyama Y, et al. Silencing of tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis. Cancer Lett. 2010;296(1):27–34.
   PubMed Web of Science ®Google Scholar
• Li C, Tang Z, Zhang W, et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242–W246.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. String v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43 issue):D447–452.
   PubMedGoogle Scholar
• Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Ferrandon S, DeVecchio J, Duraes L, et al. CoA Synthase (COASY) mediates radiation resistance via PI3K signaling in rectal cancer. Cancer Res. 2020;80(2):334–346.
   PubMed Web of Science ®Google Scholar
• Yang IH, Jung JY, Kim SH, et al. ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein. Cell Oncol. 2019;42(3):357–368.
   Web of Science ®Google Scholar
• Zhangyuan G, Wang F, Zhang H, et al. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway. Oncogene. 2020;39(6):1213–1230.
   PubMed Web of Science ®Google Scholar
• Morshed RA, Young JS, Hervey-Jumper SL, et al. The management of low-grade gliomas in adults. J Neurosurg Sci. 2019;63(4):450–457.
   PubMed Web of Science ®Google Scholar
• Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol. 2018;51:50–58.
   PubMed Web of Science ®Google Scholar
• Zhu H, Ouyang H, Pan X, et al. Increased ASF1B expression correlates with poor prognosis in patients with gliomas. Front Oncol. 2022;12:912101.
   PubMed Web of Science ®Google Scholar
• Zhang W, Gao Z, Guan M, et al. ASF1B Promotes oncogenesis in lung adenocarcinoma and other cancer types. Front Oncol. 2021;11(731547):731547.
   PubMedGoogle Scholar
• Wang W, Xiao L, Pan D, et al. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signalling pathway. Neoplasma. 2022;69(2):361–369.
   PubMed Web of Science ®Google Scholar
• Misiewicz-Krzeminska I, Sarasquete ME, Quwaider D, et al. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica. 2013;98(4):640–648.
   PubMed Web of Science ®Google Scholar
• Ouyang X, Lv L, Zhao Y, et al. ASF1B serves as a potential therapeutic target by influencing cell cycle and proliferation in hepatocellular carcinoma. Front Oncol. 2021;11(801506):801506.
   PubMedGoogle Scholar
• Montes de Oca R, Gurard-Levin ZA, Berger F, et al. The histone chaperone HJURP is a new independent prognostic marker for luminal a breast carcinoma. Mol Oncol. 2015;9(3):657–674.
   PubMed Web of Science ®Google Scholar
• Segura-Bayona S, Stracker TH. The tousled-like kinases regulate genome and epigenome stability: implications in development and disease. Cell Mol Life Sci. 2019;76(19):3827–3841.
   PubMed Web of Science ®Google Scholar
• Klimovskaia IM, Young C, Stromme CB, et al. Tousled-like kinases phosphorylate Asf1 to promote histone supply during DNA replication. Nat Commun. 2014;5:3394.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen X, Liang Q, et al. Inhibiting of circ-TLK1 inhibits the progression of glioma through down-regulating PANX1 via targeting miR-17-5p. J Mol Histol. 2021;52(5):1007–1020.
   PubMed Web of Science ®Google Scholar